Daily Archives: August 8, 2020

Navalsig and Tweespruit police stations temporarily closed for decontamination due covid-19 related incident

FREE STATE – All communities that are serviced by Navalsig and Tweespruti police stations are advised that the stations will be temporarily closed for decontamination after some if its members tested positive

Police arrest 2 rape suspects

EASTERN CAPE – Graaff-Reinet Family Violence, Child Protection and Sexual Offences unit (FCS) and members of Graaff-Reinet Operational Command Center arrested 2 men suspected to be involved in the rape of 3

Barberton police station temporarily closed

MPUMALANGA – All communities serviced by the Barberton Police Station, are advised that this police station will be temporarily closed due to a member who tested positive for the Covid-19 virus.
The

Première biopsie liquide à recevoir l’approbation de la FDA pour le profilage complet des tumeurs dans tous les cancers solides, le diagnostic compagnon Guardant360® de Guardant Health gagne en crédibilité auprès des oncologues en Asie, au Moyen-Orient et en Afrique.

SINGAPOUR, 8 août 2020 /PRNewswire/ — La Food and Drug Administration (FDA) des États-Unis a approuvé la biopsie liquide de Guardant Health, le diagnostic compagnon Guardant360®, pour le profilage des mutations tumorales chez

Première biopsie liquide à recevoir l’approbation de la FDA pour le profilage complet des tumeurs dans tous les cancers solides, le diagnostic compagnon Guardant360® de Guardant Health gagne en crédibilité auprès des oncologues en Asie, au Moyen-Orient et en Afrique.

SINGAPOUR, 8 août 2020 /PRNewswire/ — La Food and Drug Administration (FDA) des États-Unis a approuvé la biopsie liquide de Guardant Health, le diagnostic compagnon Guardant360®, pour le profilage des mutations tumorales chez

First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health’s Guardant360® CDx, gains credibility among oncologists in Asia, Middle East and Africa.

SINGAPORE, Aug. 8, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Guardant Health’s liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers.